Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells-Reference-Cited by-同舟云学术

Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells

Published:2010-11 Issue:9 Volume:80 Page:1326-1334
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Tyagi Shilpa,Bhui Kulpreet,Singh Richa,Singh Madhulika,Raisuddin Sheikh,Shukla Yogeshwer

Funder

CSIR (India)

Supra Institutional Project (SIP-08)

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference34 articles.

1. WHO, World Health Organization, 4th May 2010. http://www.who.int/uv/faq/skincancer/en/index1.html.

2. Chemotherapy in head and neck cancer;Hamasaki;Curr Opin Oncol,1992

3. Long-term results after chemoradiotherapy for locally confined squamous-cell head and neck cancer;Adelstein;Am J Clin Oncol,1990

4. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy;Pace;J Clin Oncol,2003

5. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents;Schweitzer;Laryngoscope,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Juxtaposition of Allosteric and Catalytic Inhibition in PLK1: Tradeoff for Chemotherapy and Thermodynamic Profiles of KBJK557 and BI 6727;Journal of Computational Biophysics and Chemistry;2024-01-25

2. A novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase;Biochemical Pharmacology;2024-01

3. Characteristics and prognostic significance of polo‐like kinase‐1 (PLK1) expression in breast cancer;Histopathology;2023-05-24

4. Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification;International Journal of Molecular Sciences;2022-09-17

5. Present and Future Perspective on PLK1 Inhibition in Cancer Treatment;Frontiers in Oncology;2022-06-02